Meklēt instrumentus
GW Pharmaceuticals PLC
GW Pharmaceuticals PLC is a biopharmaceutical company that specializes in developing and commercializing innovative therapeutics from its proprietary cannabinoid product platform. Its flagship product, Epidiolex, is the first FDA-approved prescription cannabidiol (CBD) medicine for treating seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients aged two years and above. The company is also working on a pipeline of cannabinoid-based medicines for treating various diseases, such as autism spectrum disorders, glioma, and schizophrenia. GW Pharmaceuticals is dedicated to advancing the science of cannabinoid-based medicines and enhancing the quality of life for patients suffering from debilitating conditions.Instrument specification in OANDA
Sāciet tirgot tagad ar ātru konta atvēršanu.
Reģistrējieties tagad, lai tirgotos aktīvākajos tirgos
ATVER KONTU